PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines
{{output}}
Objective: PrabotulinumtoxinA-xvfs (Jeuveau), a botulinum toxin type A, was approved by the Food and Drug Administration for the temporary improvement in the appearance of moderate-to-severe glabellar lines in February 2019. This... ...
